MR编号 | AT/H/0893/001 |
---|
药品名称 | Oxaliplatin 5 mg/ml Concentrate for Solution for Infusion |
---|
活性成分 | |
---|
剂型 | Concentrate for solution for infusion |
---|
上市许可持有人 | Fresenius Kabi Austria GmbH .
Hafnerstrasse 36
8055 Graz
Austria
RMS change from UK/H/4134/001
UNITED KINGDOM |
---|
参考成员国 - 产品名称 | Austria (AT) |
---|
互认成员国 - 产品名称 | - United Kingdom (Northern Ireland) (XI)
PL 18727/0012-0030 - Belgium (BE)
- Luxembourg (LU)
- Sweden (SE)
Oxaliplatin Fresenius Kabi - Latvia (LV)
- Lithuania (LT)
Oxaliplatin Kabi 5 mg/ml koncentratas infuziniam tirpalui - Estonia (EE)
OXALIPLATIN KABI 5MG/ML - Romania (RO)
Oxaliplatin Kabi 5 mg/ml concentrat pentru solutie perfuzabila - Slovenia (SI)
|
---|
许可日期 | 2010/12/11 |
---|
最近更新日期 | 2024/07/12 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:[not specified]
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|